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cross-cultural validity in an international HIV clinical trial.
METHODS: The SDM was included in a Phase IIb/III trial to
assess symptoms perceived by HIV-1-infected treatment-naïve
patients. The cross-cultural validity of 25 language versions of
the SDM was assessed using baseline data of 759 patients from 3
treatment arms, each having received zidovudine and lamivudine
in addition to one of the following: maraviroc 300 mg QD,
maraviroc 300 mg BID (approved dose for treatment-
experienced patients) and efavirenz 600 mg QD. Given the large
number of versions, creating relatively homogeneous cultural
groups was necessary for analysis. Seven cultural groups were
deﬁned according to language and geographical considerations:
European Germanic, Polish, European Romance, Occidental
English, American Spanish, Bantu and African Indo-European.
The cross-cultural validity of the SDM was assessed by applying
ordinal logistic regressions to detect Differential Item Function-
ing (DIF), and using the STATIS approach, which explores dis-
tances between item correlation matrices. RESULTS: Most items
did not function differentially between cultural groups: only four
symptoms showed DIF (fatigue, fevers, feeling anxious and head-
ache) and the greatest cultural differences were observed for
fatigue. The African Indo-European versions of the ASDM pre-
sented the highest number of differences from the other versions.
With the STATIS approach, the Bantu and European Germanic
groups were the furthest from the Occidental English but no clear
meaningful difference was found in the expressed symptom
pattern across cultural groups. CONCLUSION: Considering the
substantial heterogeneity of cultures included in the study, these
statistical ﬁndings, together with the rigorous methodology
applied for the linguistic validation of the questionnaire, support
the cross-cultural validity of the SDM. These ﬁndings also indi-
cate that culture has a limited impact on the symptoms expressed
by HIV-1-positive individuals starting antiretroviral therapy.
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OBJECTIVE: An estimated 29% to 91% of HIV-infected
patients use complementary and alternative medications (CAM).
The objective was to identify the most commonly used CAM by
HIV-infected patients and determine the prevalence of associated
adverse events (AEs). METHODS: A single-center, prospective,
cross-sectional study was conducted from February to July 2007
via convenient sampling. Inclusion criteria were: HIV-positive
adults and using at least one CAM in the prior 12 weeks. Patient
information (including demographics, CAM use, concomitant
medication use, CAM-related AEs, purchasing behavior) was
obtained using self-administered questionnaire and personal
interview techniques. This study was approved by the institu-
tion’s IRB and informed consent was obtained prior to enroll-
ment. Descriptive statistics were performed to evaluate trends
and assess AE outcomes (SAS Version 9.0). RESULTS: One
hundred individuals participated in the survey, with a response
rate of 71.9%. Subjects were 45.0(9.9) mean(SD) years, 70%
male, 54% Black, 32% Caucasian, 8% Hispanic, and 2% Asian.
Fifty-ﬁve percent had a current/previous AIDS diagnosis.
Forty-eight different CAM were used, and 96% of respondents
were taking concomitant antiretroviral medications. The most
common CAM consumed were: cranberry juice (72%), vitamin
C (37%), green tea (34%), and garlic (8%). Most respondents
(87%) purchased herbal medications on their own, and mostly
from the grocery store (56%). Sixty-four percent of respondents
did not inform their providers about CAM use. Fifteen percent
experienced AEs that were CAM-related. Nausea and vomiting
(33%) were the most frequent AEs reported. Eighty-six percent
of subjects experiencing AEs neither consulted their physicians
nor stopped using CAM that were thought to cause the AE.
CONCLUSION: HIV-infected patients frequently use CAM con-
comitantly with traditional antiretroviral medications. Physi-
cians and pharmacists should document and provide adequate
education/counseling regarding CAM, especially for HIV-
infected patients, to prevent drug interactions and AEs. More
studies are needed regarding CAM utilization, safety, and its
economic impact.
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OBJECTIVE: Designing and testing a reliable and valid survey
for comparing HIV patients’ satisfaction with services provided
by mail order with those provided by a community pharmacy.
METHODS: Exploratory cross-sectional design using conve-
nience sample of HIV patients at a University Clinic. The satis-
faction scale was developed from previously validated instrument
(a = 0.957 & a = 0.962 for factor 1 & 2 respectively). This scale
was used for all three settings i.e. mail-order, independent, and
chain pharmacies. Practicing pharmacists, graduate students, and
pharmacy faculty assessed face and content validity. Clinical
pharmacists checked for patient ease of understanding, length,
and sensitive items. Students evaluated survey completion time.
Faculty members determined ease of understanding, time of
completion, research soundness, and objective match. Modiﬁca-
tions were made followed by data collection for six-weeks. Reli-
ability tests and item analyses were conducted. Data were entered
using SPSS v.15. RESULTS: Forty-seven surveys were completed.
Item-objective match ranged from 75–90%. Item means ranged
from 2.50 to 4.44 for factor 1 and 2.27 to 4.36 for factor 2 for
mail-order, 2.33 to 3.93 and 2.85 to 3.85 for independent, and
3.00 to 4.69 and 3.09 to 4.09 for chain. Response variability for
most items were above 0.9 using Factor ‘V’. Corrected item-total
correlations ranged from 0.484 to 0.902 and 0.606 to 0.907 for
factor 1 and 2 respectively for mail-order, 0.577 to 0.965 and
0.858 to 0.960 for independent, and -0.35 to 0.862 and 0.599 to
0.932 for chain. None of the items if deleted would increase
alpha. Cronbach’s alpha for factor 1 were 0.879 for mail, 0.960
for independent, and 0.803 for chain and for factor 2 were 0.950
for mail, 0.983 for independent, and 0.969 for chain. CONCLU-
SION: Analysis indicates good face and content validity, and high
reliability. Item analyses indicate items are well written and have
good response location, variability, and discrimination.
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OBJECTIVE: To estimate the rate of progression to cirrhosis for
those infected with Chronic Hepatitis C virus (HCV) through
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